Using words like ‘factors,’ ‘denominators’ and ‘multiples’ may be part of a constellation of good math teaching practices ...

Find out how many cats it takes to pull a sled. Trump proposes new monument near Lincoln Memorial An American dream at risk: What happens to a small Nebraska town when 3,200 workers lose their jobs ...

Lane Kiffin’s move to LSU from Ole Miss was rated A+ in ESPN’s latest coaching carousel rankings, making it the top coaching hire in the 2025-26 cycle. A move likely to further upset Ole Miss fans. In ...

University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” PRINT technology it hopes will fuel a new wave of genetic medicine. Addition emerges from stealth with ...

Every year throughout the history of college football, there are many that aspire to win but there is only one winner. In the majority of cases, players and teams are willing to accept that within the ...

ORLANDO, Fla. – Steven Matz, who spent the second half of the ’25 season in the Red Sox bullpen, has a two-year deal with their division-rival Tampa Bay Rays, pending a physical. The veteran ...

I don’t typically write responses to other opinion pieces, but there was one two weeks ago about new techniques in elementary math education that has inspired me. The main complaint was that there are ...

Apple, Amazon, Lockheed Martin, Microsoft, Google, Coinbase, Comcast and Meta are just some of the major companies who have made donations to build President Donald Trump’s proposed 90,000-square-foot ...

Unity Software is rated a buy, positioned at an inflection point for double-digit growth, driven by its CS and GS segments and the Vector launch. U's new Vector AI ad platform is a game-changer, ...

Math has always been a tricky subject for many of us, abstract, rigid, and often intimidating. But thanks to artificial intelligence (AI), that’s not the case anymore. AI-powered tools are ...

Bristol Myers Squibb has ended its R&D losing streak with a hit on one of the dual primary endpoints in a phase 3 multiple myeloma trial. But with the study continuing to evaluate the other primary ...